IL122815A0 - Oxazolidinone derivatives process for preparing the same and medicaments that contain these compounds - Google Patents
Oxazolidinone derivatives process for preparing the same and medicaments that contain these compoundsInfo
- Publication number
- IL122815A0 IL122815A0 IL12281596A IL12281596A IL122815A0 IL 122815 A0 IL122815 A0 IL 122815A0 IL 12281596 A IL12281596 A IL 12281596A IL 12281596 A IL12281596 A IL 12281596A IL 122815 A0 IL122815 A0 IL 122815A0
- Authority
- IL
- Israel
- Prior art keywords
- medicaments
- preparing
- compounds
- contain
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19524765A DE19524765A1 (de) | 1995-07-07 | 1995-07-07 | Neue Oxazolidinonderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
PCT/EP1996/002939 WO1997003072A1 (fr) | 1995-07-07 | 1996-07-04 | Derives nouveaux d'oxazolidinone, leur procede de preparation et medicaments contenant ces composes |
Publications (1)
Publication Number | Publication Date |
---|---|
IL122815A0 true IL122815A0 (en) | 1998-08-16 |
Family
ID=7766252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12281596A IL122815A0 (en) | 1995-07-07 | 1996-07-04 | Oxazolidinone derivatives process for preparing the same and medicaments that contain these compounds |
Country Status (19)
Country | Link |
---|---|
US (1) | US5972947A (fr) |
EP (1) | EP0839147A1 (fr) |
JP (1) | JPH11508904A (fr) |
KR (1) | KR19990028792A (fr) |
CN (1) | CN1195348A (fr) |
AU (1) | AU709208B2 (fr) |
BR (1) | BR9609327A (fr) |
CA (1) | CA2225411A1 (fr) |
CZ (1) | CZ288619B6 (fr) |
DE (1) | DE19524765A1 (fr) |
HU (1) | HUP9900348A3 (fr) |
IL (1) | IL122815A0 (fr) |
NO (1) | NO310194B1 (fr) |
NZ (1) | NZ313599A (fr) |
PL (1) | PL324436A1 (fr) |
SK (1) | SK298A3 (fr) |
TW (1) | TW332206B (fr) |
WO (1) | WO1997003072A1 (fr) |
ZA (1) | ZA965712B (fr) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP9901741A3 (en) * | 1996-03-30 | 2000-03-28 | Roche Diagnostics Gmbh | Novel oxazolidine derivatives, process for their production and medicaments containing them |
AR012443A1 (es) * | 1997-04-16 | 2000-10-18 | Uriach & Cia Sa J | Nuevas carboxamidas como inhibidores de la agregacion plaquetaria, procedimiento para su preparacion, composiciones farmaceuticas que loscontienen y uso de los mismos en la manufactura de medicamentos |
AR013693A1 (es) * | 1997-10-23 | 2001-01-10 | Uriach & Cia Sa J | Nuevas piperidinas y piperazinas como inhibidores de la agregacion plaquetaria |
DE19962924A1 (de) | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
DE10129725A1 (de) * | 2001-06-20 | 2003-01-02 | Bayer Ag | Kombinationstherapie substituierter Oxazolidinone |
JPWO2003095446A1 (ja) * | 2002-05-09 | 2005-09-15 | 持田製薬株式会社 | 1−(4−ピリジル)−4−ピペリドンの製造方法 |
DE10300111A1 (de) | 2003-01-07 | 2004-07-15 | Bayer Healthcare Ag | Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid |
DE10355461A1 (de) | 2003-11-27 | 2005-06-23 | Bayer Healthcare Ag | Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung |
CN101094846A (zh) * | 2004-10-18 | 2007-12-26 | 伊莱利利公司 | 用作mglur3受体拮抗剂的1-(杂)芳基-3-氨基-吡咯烷衍生物 |
DE102004062475A1 (de) * | 2004-12-24 | 2006-07-06 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung |
EP1685841A1 (fr) | 2005-01-31 | 2006-08-02 | Bayer Health Care Aktiengesellschaft | Prevention et traitement de troubles thromboemboliques |
DE102005045518A1 (de) | 2005-09-23 | 2007-03-29 | Bayer Healthcare Ag | 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung |
DE102005047561A1 (de) | 2005-10-04 | 2007-04-05 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung |
DE102005047558A1 (de) * | 2005-10-04 | 2008-02-07 | Bayer Healthcare Ag | Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen |
NZ567092A (en) | 2005-10-04 | 2011-05-27 | Bayer Schering Pharma Ag | Novel polymorphous form and the amorphous form of 5-chloro-N-({ (5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide |
DE102005048824A1 (de) * | 2005-10-10 | 2007-04-12 | Bayer Healthcare Ag | Behandlung und Prophylaxe von Mikroangiopathien |
DE102006051625A1 (de) * | 2006-11-02 | 2008-05-08 | Bayer Materialscience Ag | Kombinationstherapie substituierter Oxazolidinone |
DE102007018662A1 (de) | 2007-04-20 | 2008-10-23 | Bayer Healthcare Ag | Oxazolidinone zur Behandlung und Prophylaxe von pulmonaler Hypertonie |
DE102007028318A1 (de) | 2007-06-20 | 2008-12-24 | Bayer Healthcare Ag | Oxazolidinone zur Behandlung und Prophylaxe von Sepsis |
EP2138178A1 (fr) | 2008-06-28 | 2009-12-30 | Bayer Schering Pharma Aktiengesellschaft | Oxazolidinones pour le traitement de maladie pulmonaire obstructive chronique (MPOC) et/ou de l'asthme |
EP2140866A1 (fr) | 2008-07-04 | 2010-01-06 | Bayer Schering Pharma Aktiengesellschaft | Oxazolidinones pour le traitement d'états inflammatoires du tractus gastro-intestinal |
WO2014085413A1 (fr) * | 2012-11-28 | 2014-06-05 | Temple University - Of The Commonwealth System Of Higher Education | Oxazolidin-2-ones disubstituées, modulateurs de l'activité du récepteur 2b de 5-hydroxytryptamine |
US10023565B2 (en) | 2013-12-20 | 2018-07-17 | Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China | N,N′ substituted piperidinamine compounds, and preparation method and usage thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9122016D0 (en) * | 1991-10-16 | 1991-11-27 | Glaxo Group Ltd | Chemical compounds |
EP0623120A1 (fr) * | 1992-01-21 | 1994-11-09 | Glaxo Group Limited | Derives d'acide piperidineacetique servant d'inhibiteurs de l'agregation plaquettaire sanguine dependante du fibrinogene |
SK120895A3 (en) * | 1993-03-29 | 1996-06-05 | Zeneca Ltd | Pyridine derivatives, process for preparing the same and intermediate products in this process and pharmaceutical compositions containing them |
ES2134870T3 (es) * | 1993-05-01 | 1999-10-16 | Merck Patent Gmbh | Antagonistas del receptor de adhesion. |
DE4324393A1 (de) * | 1993-07-21 | 1995-01-26 | Merck Patent Gmbh | 4-Aryloxy- und 4-Arylthiopiperidinderivate |
DE4332384A1 (de) * | 1993-09-23 | 1995-03-30 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten III |
-
1995
- 1995-07-07 DE DE19524765A patent/DE19524765A1/de not_active Withdrawn
-
1996
- 1996-07-02 TW TW085108000A patent/TW332206B/zh active
- 1996-07-04 AU AU66113/96A patent/AU709208B2/en not_active Ceased
- 1996-07-04 EP EP96925657A patent/EP0839147A1/fr not_active Withdrawn
- 1996-07-04 SK SK2-98A patent/SK298A3/sk unknown
- 1996-07-04 CA CA002225411A patent/CA2225411A1/fr not_active Abandoned
- 1996-07-04 WO PCT/EP1996/002939 patent/WO1997003072A1/fr not_active Application Discontinuation
- 1996-07-04 NZ NZ313599A patent/NZ313599A/en unknown
- 1996-07-04 CZ CZ19974233A patent/CZ288619B6/cs not_active IP Right Cessation
- 1996-07-04 IL IL12281596A patent/IL122815A0/xx unknown
- 1996-07-04 KR KR1019980700092A patent/KR19990028792A/ko not_active Application Discontinuation
- 1996-07-04 CN CN96196744A patent/CN1195348A/zh active Pending
- 1996-07-04 JP JP9505482A patent/JPH11508904A/ja active Pending
- 1996-07-04 HU HU9900348A patent/HUP9900348A3/hu unknown
- 1996-07-04 PL PL96324436A patent/PL324436A1/xx unknown
- 1996-07-04 BR BR9609327A patent/BR9609327A/pt not_active Application Discontinuation
- 1996-07-05 ZA ZA9605712A patent/ZA965712B/xx unknown
-
1998
- 1998-01-06 NO NO19980059A patent/NO310194B1/no not_active IP Right Cessation
- 1998-12-31 US US09/224,799 patent/US5972947A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU709208B2 (en) | 1999-08-26 |
KR19990028792A (ko) | 1999-04-15 |
CA2225411A1 (fr) | 1997-01-30 |
PL324436A1 (en) | 1998-05-25 |
NO980059L (no) | 1998-01-06 |
DE19524765A1 (de) | 1997-01-09 |
CZ423397A3 (cs) | 1998-03-18 |
BR9609327A (pt) | 1999-05-25 |
HUP9900348A2 (hu) | 1999-05-28 |
ZA965712B (en) | 1998-01-05 |
MX9800157A (es) | 1998-03-29 |
AU6611396A (en) | 1997-02-10 |
JPH11508904A (ja) | 1999-08-03 |
NO980059D0 (no) | 1998-01-06 |
CZ288619B6 (cs) | 2001-08-15 |
HUP9900348A3 (en) | 2000-11-28 |
TW332206B (en) | 1998-05-21 |
WO1997003072A1 (fr) | 1997-01-30 |
EP0839147A1 (fr) | 1998-05-06 |
NO310194B1 (no) | 2001-06-05 |
NZ313599A (en) | 1999-10-28 |
US5972947A (en) | 1999-10-26 |
SK298A3 (en) | 1998-05-06 |
CN1195348A (zh) | 1998-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5756817C1 (en) | O-carbamoyl-phenylananinol compounds their pharmaceutically useful salts and process for preparing the same | |
IL122815A0 (en) | Oxazolidinone derivatives process for preparing the same and medicaments that contain these compounds | |
IL117659A0 (en) | Acetamide derivative process for preparing the same and a pharmaceutical composition containing the same | |
HUP9900625A3 (en) | Benzimidazole derivatives, pharmaceutical compositions containing them and process for preparing the compounds | |
HUP9802565A3 (en) | N-benzyl-dioxothiazolidinylmethyl-benzamide derivatives, pharmaceutical compositions containing them and process for producing the same | |
HUP9702534A3 (en) | Propiophenone derivatives, process for preparing them and medicaments containing the said compounds | |
GR3029896T3 (en) | Process for preparing polyethylene | |
IL113084A0 (en) | Thiazolidine and oxazolidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
HUT72308A (en) | Thiazolidine derivatives and pharmaceutical composition containing the same, and process for their preparation | |
ZA962916B (en) | New arylglycineamide derivatives processes for the manufacture thereof and pharmaceutical compositions containing these compounds | |
HUP9901485A2 (en) | Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use | |
ZA969220B (en) | Nucleoside derivatives and process for preparing the same | |
HUP9903902A3 (en) | Bromotiacumicin compounds, process for producing them and medicaments containing the same | |
HU9602763D0 (en) | Novel isoxazole derivatives, process for producing them and pharmaceutical compositions containing the same | |
HRP931016A2 (en) | Thienothiazin derivatives, process for the preparation and application thereof | |
EP0693485A3 (fr) | Dérivés de la baccatine et procédés pour les préparer | |
HUP9600173A3 (en) | 4-amino-benzoyl-guanidine derivatives, process for preparing them and pharmaceutical compositions containing them | |
HUP9903696A2 (en) | 5-naphthalen-1-yl-1,3-dioxane derivatives, medicaments containing the same and process for producing them | |
HU914075D0 (en) | Thia-diazinone derivatives, process for producing them and pharmaceutical preparatives containing said compounds | |
HK1001395A1 (en) | 6-methoxy-1h-benzotriazole-5-carboxamide derivatives, process for producing the same, and medicinal composition containing the same | |
GB2302691B (en) | Oxaindene derivatives and process for the preparation thereof | |
IL115907A0 (en) | Process for the preparation of 1-halo-3-trialkylsilanyl-benzene derivatives | |
HU9401281D0 (en) | Heterocyclic compounds, pharmaceutical compositions containing them, and process for producing the active components | |
GB9424890D0 (en) | Process for preparing pyrolizine derivatives | |
EP0738707A3 (fr) | Composés de dianilinoglutacondialdéhyde et procédé de préparation de celui-ci |